The weekly litigation news digest is live. Subscribe now

Patent Oppositions in medicinal compounds for specific treatments industry

Explore the competitive field of medicinal compounds for specific treatments where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in medicinal compounds for specific treatments technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Jan 8, 2026
CompanyTotal Oppositions
NOVARTIS301
BOEHRINGER INGELHEIM125
AMGEN86
NOVO NORDISK78
PFIZER77
NESTLE66
NUTRICIA62
JANSSEN PHARMACEUTICA58
NESTEC54
F HOFFMANN LA ROCHE51

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the medicinal compounds for specific treatments industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the medicinal compounds for specific treatments industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jan 8, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Dna-Pkcs Inhibitors For Increasing Genome Editing EfficiencyMAX PLANCK GESELLSCHAFT ZUR FRDERUNG DER WISSENSCHAFTEN EVDec 4, 2025MAIWALD
A Myostatin Pathway Inhibitor In Combination With A Glp-1 Pathway Activator For Use In Treating Metabolic DisordersSCHOLAR ROCKDec 3, 2025MARGARET DIXON
Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell FunctionF HOFFMANN LA ROCHENov 28, 2025SANDOZ
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
A Nutritional Composition Comprising A Combination Of Human Milk Oligosaccharides To Improve The Gastrointestinal BarrierNESTLENov 25, 2025ABG LAW
A Nutritional Composition Comprising A Combination Of Human Milk Oligosaccharides To Improve The Gastrointestinal BarrierNESTLENov 24, 2025NUTRICIA
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISNov 21, 2025TEVA PHARMACEUTICALS
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKNov 20, 2025GALENICUM HEALTH SLU
Pharmaceutical Composition Comprising UdenafilCOREPHARM BIONov 19, 2025STRAWMAN

To stay ahead in the competitive medicinal compounds for specific treatments industry, companies are constantly innovating. Here are the top patents facing oppositions in the medicinal compounds for specific treatments industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jan 8, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS18
Oct 11, 2023New UseNOVARTIS17
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS15
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelSANOFI13
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA12